June 5, 2020 -- Memorial Sloan Kettering and Hackensack Meridian Health have formed an immunology research collaboration to support cancer immunotherapy research.
Three projects were selected in 2020 for funding support over two years. The projects range from exploring the creation of cancer-targeted T cells within the thymus to the impact of gut microbiota in patients with multiple myeloma. They will also fund research into the impact of the gut microbiome on stem cell transplantation.
Through the joint venture, researchers can apply for funding to support their investigations. The partnership aims to explore the immune system in both the lab and the clinic and to speed the discovery of immunotherapies.